Cover Image

An ultrasensitive UPLC-MS/MS assay for the quantification of the therapeutic peptide liraglutide in plasma to assess the oral and nasal bioavailability in beagle dogs

Show other versions (1)

Aim: An ultrasensitive UPLC-MS/MS assay for liraglutide was developed and validated according to US FDA and EMA guidelines and applied to the quantification of plasma concentrations after intravenous, nasal and oral administration of liraglutide to beagle dogs. Results: Liraglutide isolation was per...

Full description

Saved in:
Bibliographic Details
Main Authors: Sauter, Max (Author) , Uhl, Philipp (Author) , Majewsky, Marius (Author) , Fresnais, Margaux (Author) , Haefeli, Walter E. (Author) , Burhenne, Jürgen (Author)
Format: Article (Journal)
Language:English
Published: 16 May 2019
In: Bioanalysis
Year: 2019, Volume: 11, Issue: 9, Pages: 887-898
ISSN:1757-6199
DOI:10.4155/bio-2018-0322
Online Access:Verlag, Volltext: https://doi.org/10.4155/bio-2018-0322
Verlag, Volltext: https://www.future-science.com/doi/10.4155/bio-2018-0322
Get full text
Author Notes:Max Sauter, Philipp Uhl, Marius Majewsky, Margaux Fresnais, Walter E Haefeli and Jürgen Burhenne
Description
Summary:Aim: An ultrasensitive UPLC-MS/MS assay for liraglutide was developed and validated according to US FDA and EMA guidelines and applied to the quantification of plasma concentrations after intravenous, nasal and oral administration of liraglutide to beagle dogs. Results: Liraglutide isolation was performed with a combined protein precipitation and solid-phase extraction protocol. The calibrated concentration range of 0.1-200 ng/ml was linear with correlation coefficients >0.998. Precise analysis was achieved through the utilization of an isotopically labeled internal standard. Absolute bioavailability of liraglutide after nasal and oral administration of liraglutide to beagle dogs was 0.03 and 0.006%, respectively. Conclusion: The assay matches the performance in sensitivity of the previously applied immunoassay and optimally covers the therapeutic range of liraglutide.
Item Description:Gesehen am 25.10.2019
Physical Description:Online Resource
ISSN:1757-6199
DOI:10.4155/bio-2018-0322

Similar Items